Abstract
Ischaemic stroke is one of the most common diseases world-wide. Recent studies provide new insights into the role of ATPbinding cassette (ABC) transporters in brain ischaemia. Expressional and functional transporter changes that have been observed at the brain capillary endothelium during ischaemia impede the access of pharmacological compounds into the brain tissue. The current review summarizes the most important findings and discusses the role of hypoxia, inflammation, oxidative stress and lipids as factors regulating ABC transporters at the blood-brain barrier. A better understanding of biodistribution processes at the blood-brain barrier is urgently needed, so that the accumulation of drugs in the brain can be improved, enabling a successful translation of pharmacological treatments in ischaemic stroke.
Keywords: Ischaemic stroke, ABC transporters, multidrug resistance, blood-brain barrier, immunohistochemistry, Apolipoprotein E, Thrombolysis, hypoxia, Metabolic imbalance, oxidative stress
Current Pharmaceutical Design
Title: ATP-Binding Cassette Transporters at the Blood-Brain Barrier in Ischaemic Stroke
Volume: 17 Issue: 26
Author(s): Pauline Patak and Dirk M. Hermann
Affiliation:
Keywords: Ischaemic stroke, ABC transporters, multidrug resistance, blood-brain barrier, immunohistochemistry, Apolipoprotein E, Thrombolysis, hypoxia, Metabolic imbalance, oxidative stress
Abstract: Ischaemic stroke is one of the most common diseases world-wide. Recent studies provide new insights into the role of ATPbinding cassette (ABC) transporters in brain ischaemia. Expressional and functional transporter changes that have been observed at the brain capillary endothelium during ischaemia impede the access of pharmacological compounds into the brain tissue. The current review summarizes the most important findings and discusses the role of hypoxia, inflammation, oxidative stress and lipids as factors regulating ABC transporters at the blood-brain barrier. A better understanding of biodistribution processes at the blood-brain barrier is urgently needed, so that the accumulation of drugs in the brain can be improved, enabling a successful translation of pharmacological treatments in ischaemic stroke.
Export Options
About this article
Cite this article as:
Patak Pauline and M. Hermann Dirk, ATP-Binding Cassette Transporters at the Blood-Brain Barrier in Ischaemic Stroke, Current Pharmaceutical Design 2011; 17(26) . https://dx.doi.org/10.2174/138161211797440195
DOI https://dx.doi.org/10.2174/138161211797440195 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Role of Oxygen Radicals on Bronchial Asthma
Current Drug Targets - Inflammation & Allergy Lipid Mediators: Lipoxin and Aspirin-Triggered 15-Epi-Lipoxins
Inflammation & Allergy - Drug Targets (Discontinued) Dietary Polyphenols and Mitochondrial Function: Role in Health and Disease
Current Medicinal Chemistry Human Mesenchymal Stem Cell-derived Exosomes Reduce Ischemia/Reperfusion Injury by the Inhibitions of Apoptosis and Autophagy
Current Pharmaceutical Design Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide
Current Pharmaceutical Biotechnology MicroRNA Expression in Coronary Artery Disease
MicroRNA Dipyridamole: A Drug with Unrecognized Antioxidant Activity
Current Topics in Medicinal Chemistry Phylogenetic Aspects of Nucleobindin-2/Nesfatin-1
Current Pharmaceutical Design Patent Selections
Recent Patents on Cardiovascular Drug Discovery Angiogenesis as Risk Factor for Plaque Vulnerability
Current Pharmaceutical Design Redox Behavior of Ceria Nanoparticles
Recent Patents on Materials Science Modular Protein Engineering in Emerging Cancer Therapies
Current Pharmaceutical Design Effect of Doxycycline on Atherosclerosis: From Bench to Bedside
Recent Patents on Cardiovascular Drug Discovery Inhalation Gases or Gaseous Mediators As Neuroprotectants for Cerebral Ischaemia
Current Drug Targets Discovery of Lansoprazole and its Unique Pharmacological Properties Independent from Anti-secretory Activity
Current Pharmaceutical Design Vascular Protection to Increase the Safety of Tissue Plasminogen Activator for Stroke
Current Pharmaceutical Design Neurotrophic and Neuroprotective Effects of Muscle Contraction
Current Pharmaceutical Design Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
CNS & Neurological Disorders - Drug Targets The Janus Face of Adenosine: Antiarrhythmic and Proarrhythmic Actions
Current Pharmaceutical Design Role of Sensory Neurons in Restitution and Healing of Gastric Ulcers
Current Pharmaceutical Design